APELLIS PHARMACEUTICALS INC - NOTE 3.500% 9/1

25 filings reported holding 03753UAB2 - APELLIS PHARMACEUTICALS INC - NOTE 3.500% 9/1 as of Q1 2022.
APELLIS PHARMACEUTICALS INC - NOTE 3.500% 9/1 has 17 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of $199,820,000 of principal .
Largest 10 bondholders include WOLVERINE ASSET MANAGEMENT LLC ($61,374,000 of principal), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ($51,885,000 of principal), DeepCurrents Investment Group LLC ($27,550,000 of principal), UBS ASSET MANAGEMENT AMERICAS INC ($19,000,000 of principal), LAZARD ASSET MANAGEMENT LLC ($10,000,000 of principal), WELLS FARGO & COMPANY/MN ($8,325,000 of principal), Verition Fund Management LLC ($7,728,000 of principal), WELLINGTON MANAGEMENT GROUP LLP ($6,025,000 of principal), SILVERBACK ASSET MANAGEMENT LLC ($3,000,000 of principal), and Point72 Asset Management, L.P. ($3,000,000 of principal).
This table shows the top 17 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.